These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 64632)

  • 21. Hypertonic salt solution of superficial membrane proteins from ATPc+ mouse ascites tumour which retain tumour specific antigenic properties.
    Pitzurra M; Marconi P; Bistoni F
    Boll Ist Sieroter Milan; 1973; 52(4):346-8. PubMed ID: 4130350
    [No Abstract]   [Full Text] [Related]  

  • 22. Virus oncogenesis and tumor immunogenicity in the mouse mammary tumor system.
    Vaage J; Medina D
    Cancer Res; 1974 Jun; 34(6):1319-24. PubMed ID: 4363654
    [No Abstract]   [Full Text] [Related]  

  • 23. [Solubilization of antigens from ATPC+ ascitic tumor using hypertonic sodium solution].
    Marconi P; Bistoni F; Pitzurra M
    Boll Soc Ital Biol Sper; 1973 May; 49(10):534-8. PubMed ID: 4132962
    [No Abstract]   [Full Text] [Related]  

  • 24. Non-H-2 restriction specificity of tumor-regressor mouse sera with regard to their activity to inhibit tumor cell transplantation.
    Egawa K; Kiyohara T; Tanino T
    Jpn J Exp Med; 1982 Oct; 52(5):255-60. PubMed ID: 7169670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Purification of a glycoprotein bearing a tumor transplantation antigen specific for Friend, Moloney, and Rauscher MuLV-induced tumors.
    Rogers MJ; Galetto G; Hearing VJ; Siwarski DF; Law LW
    J Immunol; 1984 Jun; 132(6):3211-7. PubMed ID: 6202777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A unique tumor rejection antigen from the S91 murine malignant melanoma.
    Law LW; Vieira WD; Kameyama K; Hearing VJ
    Cancer Res; 1987 Nov; 47(22):5841-5. PubMed ID: 3664485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure of tumor antigen on hybrid cells between mouse mammary ascites tumor and mouse fibroblast L cells.
    Kubota K
    Int J Cancer; 1979 Jul; 24(1):114-20. PubMed ID: 90019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. H-2 antigens and tumour-associated transplantation antigens in clones derived from a methylcholanthrene-induced BALB/c tumour: their influence on the generation in vitro and in vivo of the specific anti-tumour immune response.
    Pérez M; Garrido A; Algarra I; Caballero A; Delgado C; Collado MD; Fernández-Cruz E; Garrido F
    Exp Clin Immunogenet; 1989; 6(3):204-18. PubMed ID: 2631798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating tumor antigens versus immune serum factors in depressed concomitant immunity.
    Vaage J
    Cancer Res; 1974 Nov; 34(11):2979-83. PubMed ID: 4425091
    [No Abstract]   [Full Text] [Related]  

  • 30. Transplantability and antigenicity of two sublines of the TA3 tumor.
    Sanford BH; Codington JF; Jeanloz RW; Palmer PD
    J Immunol; 1973 May; 110(5):1233-7. PubMed ID: 4572632
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunological analysis of A strain mice bearing the A-10 mammary adenocarcinoma.
    Tax A; Manson LA
    Cancer Res; 1979 May; 39(5):1739-47. PubMed ID: 85488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative behavior of simian virus 40 T-antigen and of tumor-specific surface and transplantation antigens during partial purification.
    Luborsky SW; Chang C; Pancake SJ; Mora PT
    Cancer Res; 1978 Aug; 38(8):2367-71. PubMed ID: 78758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biological and biochemical properties of Nonidet P40-solubilized and partially purified tumor-specific antigens of the transplantation type from plasma membranes of a methylcholanthrene-induced sarcoma.
    Natori T; Law LW; Appella E
    Cancer Res; 1977 Sep; 37(9):3406-13. PubMed ID: 69494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Haemagglutination and cytotoxic studies of H-2. V. T-e anti-27, 28, 29 family of antibodies.
    Snell GD; Démant P; Cherry M
    Folia Biol (Praha); 1974; 20(3):145-67. PubMed ID: 4136760
    [No Abstract]   [Full Text] [Related]  

  • 35. [The effect of lymph node cells and serum of normal mice and mice with cancer on the growth of isologous mammary cancer transplants].
    Welcker ER; Müller M
    Acta Biol Med Ger; 1966; 17(2):254-7. PubMed ID: 5983241
    [No Abstract]   [Full Text] [Related]  

  • 36. Relation of human blood-groups MN to cancer cell surface antigens and to receptors for oncogenic viruses.
    Springer GF; Desai PR
    Ann Clin Lab Sci; 1974; 4(4):294-8. PubMed ID: 4142544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of the immune response to transplantation antigens. II. The effects of heterologous antisera on the growth of tumour allografts in mice.
    Zola H
    Clin Exp Immunol; 1974 Mar; 16(3):461-7. PubMed ID: 4468850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mapping of SJL/J reticulum cell sarcoma tumor-associated Ia antigens by T cell hybridomas: characterization of tumor-specific and shared epitopes detected on IE+ allogeneic cells.
    Ohnishi K; Bonavida B
    J Immunol; 1986 Jul; 137(2):733-40. PubMed ID: 2424977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell-specific antigens and immunoglobulin synthesis of murine myeloma cells and their variants.
    Hyman R; Ralph P; Sarkar S
    J Natl Cancer Inst; 1972 Jan; 48(1):173-84. PubMed ID: 4119881
    [No Abstract]   [Full Text] [Related]  

  • 40. Class 1 (unique) tumor antigens of human melanoma: partial purification and characterization of the FD antigen and analysis of a mouse polyclonal antiserum.
    Mattes MJ; Real FX; Furukawa K; Old LJ; Lloyd KO
    Cancer Res; 1987 Dec; 47(24 Pt 1):6614-9. PubMed ID: 2445475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.